Role of dietary interventions on microvascular health in South-Asian Surinamese people with type 2 diabetes in the Netherlands: A randomized controlled trial.

Bernard M van den Berg, Hans Vink, Johan van der Vlag, Ton J Rabelink, Hanno Pijl, Anouk I M van der Velden, Daphne H T IJpelaar, Prataap K Chandie Shaw

Journal: Nutrition & diabetes 2024;14(1):17

PMID: 38600065

Abstract

BACKGROUND/OBJECTIVES

We investigated whether dietary interventions, i.e. a fasting mimicking diet (FMD, Prolon®) or glycocalyx mimetic supplementation (Endocalyx) could stabilize microvascular function in Surinamese South-Asian patients with type 2 diabetes (SA-T2DM) in the Netherlands, a patient population more prone to develop vascular complications.

SUBJECTS/METHODS

A randomized, placebo controlled, 3-arm intervention study was conducted in 56 SA-T2DM patients between 18 and 75 years old, for 3 consecutive months, with one additional follow up measurement 3 months after the last intervention. Sublingual microcirculation was assessed with SDF-imaging coupled to the GlycoCheck software, detecting red blood cell velocity, capillary density, static and dynamic perfused boundary region (PBR), and the overall microvascular health score (MVHS). Linear mixed models and interaction analysis were used to investigate the effects the interventions had on microvascular function.

RESULTS

Despite a temporal improvement in BMI and HbA1c after FMD the major treatment effect on microvascular health was worsening for RBC-velocity independent PBR, especially at follow-up. Glycocalyx supplementation, however, reduced urinary MCP-1 presence and improved both PBR and MVHS, which persisted at follow-up.

CONCLUSIONS

We showed that despite temporal beneficial changes in BMI and HbA1c after FMD, this intervention is not able to preserve microvascular endothelial health in Dutch South-Asian patients with T2DM. In contrast, glycocalyx mimetics preserves the microvascular endothelial health and reduces the inflammatory cytokine MCP-1.

CLINICAL STUDY REGISTRATION

NCT03889236.

© 2024. The Author(s).

Address: Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory of Vascular and Regenerative Medicine, LUMC, Leiden, The Netherlands.; Department of Internal Medicine and Nephrology, Green Heart Hospital, Gouda, The Netherlands.; Department of Internal Medicine and Nephrology, Haaglanden Medical Center, The Hague, The Netherlands.; Einthoven Laboratory of Vascular and Regenerative Medicine, LUMC, Leiden, The Netherlands.; Department of Internal Medicine (Endocrinology), LUMC, Leiden, The Netherlands.; Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.; MicroVascular Health Solutions LLC, Alpine, Utah, USA.; Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, The Netherlands. [email protected].; Einthoven Laboratory of Vascular and Regenerative Medicine, LUMC, Leiden, The Netherlands. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.